Animal Models to Evaluate Nanoparticulate Ocular Drug Delivery Systems
Ophthalmic injuries and diseases can be devastating, especially when eyesight is at risk. Steps have been taken to enhance treatment options for patients with conditions such as glaucoma or fungal eye infections, to name a few. Nanoparticle ophthalmologic drug delivery offers a chance for a more effective treatment against many common eye malignancies by increasing the efficacy of many current eye medications. Additionally, nanoparticles open a door to new treatment approaches, such as sustained release for chronic conditions or for drugs with low patient compliance, by discovering new drug delivery methods. Without the use of animal models in medical research, we would not be able to take great strides in the direction of optimum patient health. Evaluation of these modern drug delivery systems in animal models shows great promise for the future of ophthalmologic health.
KeywordsOcular drug Animal studies Nanoparticles Glaucoma Ocular infection Ocular cancer
- 9.Lexi-Comp, Inc. (Lexi-DrugsTM) (2014) Lexi-Comp, Inc.Google Scholar
- 12.http://www.glaucoma.org/glaucoma/. Accessed 25 Oct 2014
- 13.http://www.mayoclinic.org/diseases-conditions/glaucoma/basics/causes/con-20024042. Accessed 25 Oct 2014
- 15.Adair TH, Montani JP (2010) Angiogenesis. Morgan and Claypool Life Sciences, San RafaelGoogle Scholar